Lv1
46 积分 2025-03-04 加入
Long-Term Favorable Cardiac Remodeling in Obstructive Hypertrophic Cardiomyopathy Patients Treated With Mavacamten for up to 128 Weeks
1个月前
已完结
Population Pharmacokinetic Modeling of Subcutaneous Plozasiran in Healthy Volunteers and Patients with Familial Chylomicronemia Syndrome, Severe Hypertriglyceridemia, and Mixed Hyperlipidemia
1个月前
已完结
Hypertriglyceridemia Acute Pancreatitis: Animal Experiment Research
1个月前
已完结
Olezarsen: First Approval
1个月前
已完结
Olezarsen for the Treatment of Familial Chylomicronemia Syndrome
1个月前
已完结
Drug Therapy for Hypertriglyceridemia and Familial Chylomicronemia Syndrome: Focus on Volnesorsen
1个月前
已完结
Volanesorsen: First Global Approval
1个月前
已完结
Apical Hypertrophic Cardiomyopathy: A Clinical & Multimodality Imaging Assessment
1个月前
已完结
Detection of hypertrophic cardiomyopathy by an artificial intelligence electrocardiogram in children and adolescents
2个月前
已完结
Enhancement of the Mayo Clinic HCM Genotype Predictor Score with Addition of Cardiac Magnetic Resonance Imaging
2个月前
已完结
皖公网安备34019202002308
